NB

Nitin Bansal

Active Director Director DIN 08884575
DIN 08884575 First appointment Sep 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2020
Shareholding value •••• Premium profile

About Nitin Bansal

Data last updated:

Nitin Bansal is a Director at Enrobage India Private Limited (since 2020). The company operates in Pharma. Enrobage India Private Limited reported revenue of ₹7.03 Cr (FY 2023).

DIN 08884575
Primary Designation Director
Industry Pharma
First Appointment 18 Sep 2020
Oldest Company Age 6 yrs
Largest company Enrobage India Private Limited · ₹7.03 Cr (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Enrobage India Private Limited U24296HR2020PTC089434
Director18 Sep 20202020₹7.03 Cr (FY 2023)Active

Board colleagues of Nitin Bansal

Directorship timeline

Open interactive timeline →
Enrobage India Private Limited
Premium access

Shareholding and investment profile for Nitin Bansal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nitin Bansal

Nitin Bansal currently holds 1 directorship: Enrobage India Private Limited (Director, since 18 Sep 2020, revenue ₹7.03 Cr (FY 2023)).

Nitin Bansal was first appointed on 18 Sep 2020 as Director at Enrobage India Private Limited.

The current boards of Nitin Bansal's companies include Aditya Gupta (Enrobage India Private Limited), Nand Kishore Joshi (Enrobage India Private Limited), Yug Garg (Enrobage India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available